Skip to main content

Advertisement

Table 2 Multivariate logistic regression modelling in patients with diabetes

From: The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin

Variable Adjusted OR 95 % CI P value
Clinical Success (mITT Population)
 End of Treatment
  Vasopressors at Baseline (Yes vs No) 0.4 (0.2, 1.1) 0.073
  Treatment (LZD vs. VAN) 2.8 (1.2, 6.8) 0.022
  Bacteremia (Yes vs No) 0.2 (0.1, 0.7) 0.009
  Combined MIC (vs. 0.5)
   1 1.5 (0.2, 9.1) 0.673
   2 or 4 0.4 (0.1, 3.2) 0.384
  Pneumonia Type
   HCAP vs. HAP 2.9 (0.6, 13.7) 0.176
   VAP vs. HAP 0.6 (0.2, 1.5) 0.239
   HCAP vs. VAP 5.2 (1.3, 21.6) 0.023
  Smoking Status
   Current vs. Non-Smoker 0.9 (0.3, 2.4) 0.774
   Ex vs. Non-Smoker 2.3 (0.8, 6.1) 0.105
 End of Study
  Vasopressors at Baseline 0.3 (0.1, 0.8) 0.019
  Race (vs White)
   Asian 4.9 (1.7, 13.6) 0.002
   Black 1.7 (0.7, 4.3) 0.281
   Other 1.1 (0.2, 5.5) 0.885
Day 28 Mortality (mITT population)
 Age (10 years) 1.4 (1.1, 1.9) 0.014
 Chronic Dialysis Care (Yes vs No) 5.9 (1.8, 19.6) 0.004
 Race (vs. White)
  Asian 0.1 (0.0, 0.5) 0.004
  Black 1.0 (0.4, 2.6) 0.987
  Other 0.8 (0.1, 3.9) 0.735
 Subject Type (vs. Medical)
  Surgical 1.0 (0.4, 2.2) 0.921
  Trauma 1.3 (0.4, 5.1) 0.665
 Bacteremia (Yes vs. No) 2.2 (0.8, 6.0) 0.115
 Pleural Effusion (Yes vs. No) 0.5 (0.2, 1.0) 0.040
  1. CI confidence interval, mITT modified intent-to-treat OR odds ratio